ITGR - Integer Holdings Corporation
NEXT EARNINGS:
Apr 23, 2026
(in 30 days)
EPS Est: $1.19
|
Rev Est: $426.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$102.75
DETAILS
HIGH:
$133.00
LOW:
$82.00
MEDIAN:
$98.00
CONSENSUS:
$102.75
UPSIDE:
20.41%
Market Cap:
2.99B
Volume:
764,661
Avg Volume:
810,188
52 Week Range:
62-127.56
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.74
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
11,000
IPO Date:
2000-09-29
EPS (TTM):
2.92
P/E Ratio:
29.22
Revenue (TTM):
1.85B
Total Assets:
3.41B
Total Debt:
1.40B
Cash & Equiv:
17.16M
Rev Growth (5Y):
11.5%
EPS Growth (5Y):
4.7%
FCF Growth (5Y):
-4.1%
ROCE:
5.3%
Debt/Equity:
0.80
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-19 | $1.76 | $1.70 | +3.5% | $472.1M | $425.3M | +11.0% |
| 2025-10-23 | $1.79 | $1.68 | +6.5% | $467.7M | $462.7M | +1.1% |
| 2025-07-24 | $1.55 | $1.57 | -1.3% | $476.5M | $466.5M | +2.2% |
| 2025-04-24 | $1.31 | $1.27 | +3.1% | $437.4M | $428.7M | +2.0% |
| 2025-02-20 | $1.43 | $1.46 | -2.1% | $449.5M | $437.1M | +2.8% |
| 2024-10-24 | $1.43 | $1.36 | +5.1% | $431.4M | $447.0M | -3.5% |
| 2024-07-25 | $1.30 | $1.24 | +4.8% | $436.6M | $437.0M | -0.1% |
| 2024-04-25 | $1.14 | $1.12 | +1.8% | $414.8M | $412.8M | +0.5% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.85B | 1.72B | 1.56B | 1.33B | 1.22B | 1.07B | 1.26B | 1.22B | 1.14B | 1.08B | 800.41M | 687.79M |
| Net Income | 102.81M | 119.90M | 90.65M | 66.38M | 96.81M | 77.26M | 96.34M | 167.96M | 66.68M | 5.96M | (7.59M) | 55.46M |
| EPS | 2.96 | 3.60 | 2.72 | 1.97 | 2.82 | 2.35 | 2.80 | 5.23 | 2.12 | 0.19 | -0.29 | 2.23 |
| Total Assets | 3.41B | 3.08B | 2.94B | 2.79B | 2.58B | 2.37B | 2.35B | 2.33B | 2.85B | 2.83B | 2.98B | 956.01M |
| Total Debt | 1.40B | 1.10B | 1.05B | 1.01B | 905.81M | 777.55M | 859.39M | 925.51M | 1.61B | 1.73B | 1.71B | 186.61M |
| Cash & Equivalents | 17.16M | 46.54M | 23.67M | 24.27M | 17.89M | 49.21M | 13.54M | 25.57M | 44.10M | 52.12M | 82.48M | 76.82M |
| Operating Cash Flow | 196.15M | 205.21M | 180.21M | 116.38M | 156.67M | 181.34M | 165.36M | 167.30M | 149.36M | 105.53M | 12.48M | 81.28M |
| Free Cash Flow | 105.12M | 99.60M | 60.27M | 41.65M | 103.20M | 129.90M | 117.16M | 122.39M | 102.06M | 46.90M | (32.14M) | 56.45M |
| FCF per Share | 3.03 | 2.96 | 1.81 | 1.26 | 3.13 | 3.96 | 3.59 | 3.81 | 3.25 | 1.52 | -1.23 | 2.27 |
| Book Value | 1.75B | 1.62B | 1.52B | 1.42B | 1.35B | 1.27B | 1.15B | 1.06B | 893.38M | 725.24M | 850.62M | 613.36M |
| Cash & ST Investments | 17.16M | 46.54M | 23.67M | 24.27M | 17.89M | 49.21M | 13.54M | 25.57M | 44.10M | 52.12M | 82.48M | 76.82M |
| ROC Equity | 0.06 | 0.07 | 0.06 | 0.05 | 0.07 | 0.06 | 0.08 | 0.16 | 0.07 | 0.01 | -0.01 | 0.09 |